First Turn Management »

Apogee Therapeutics shares owned by First Turn Management

Quarter-by-quarter ownership of Apogee Therapeutics (APGE) shares owned by First Turn Management from 13F filings

Historical chart of First Turn Management investment in Apogee Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Apogee Therapeutics held by First Turn Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Apogee Therapeutics by First Turn Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $25M 380k 66.45

More positions owned by First Turn Management

Shockwave Med (SWAV)
Argenx Se Sponsored Adr (ARGX)
Cytokinetics Com New (CYTK)
Xenon Pharmaceuticals (XENE)
Sarepta Therapeutics (SRPT)
Axsome Therapeutics (AXSM)
Dex (DXCM)
Immunocore Hldgs Ads (IMCR)
Apogee Therapeutics (APGE)
Vertex Pharmaceuticals Incorporated (VRTX)
Mirum Pharmaceuticals (MIRM)
Biohaven (BHVN)
Krystal Biotech (KRYS)
Ascendis Pharma A/s Sponsored Adr (ASND)
Transmedics Group (TMDX)

View all positions for First Turn Management

Top funds holding Apogee Therapeutics

VR Adviser
FMR
BlackRock
Perceptive Advisors
Fairmount Funds Management
RA Capital Management
Vanguard Group
Braidwell
Wellington Management Company
T. Rowe Price Associates
Franklin Resources
Darwin Global Management
Geode Capital Management
OrbiMed Advisors
Woodline Partners

View all funds holding Apogee Therapeutics